Research & Reports

Today, the Center for Financial Services Innovation (CFSI) and Core Innovation Capital (Core) released their sixth annual Financially Underserved Market Size Study. The report, which benefited from the financial support and strategic input of Morgan Stanley and with additional financial support from CFSI’S Founding Partner the Ford Foundation, reveals that underserved American consumers spent $141 billion in fees and interest in 2015, generated from a volume of $1.6 trillion in financial activity.

A new study released by CECP and supported by Prudential Financial, Inc. found that large corporations invest approximately US$2.4 billion each year in initiatives and ventures designed to achieve financial returns as well as a positive economic, social, or environmental impact – commonly referred to as “impact investing.” The groundbreaking pilot study, Investing with Purpose, is the first time that the corporate role in impact investing has been analyzed in depth.

This one-day interactive workshop will give you an opportunity to explore issues and develop a materiality matrix for your industry sector and your company in a practical way.

This workshop enhances your reporting capability, highlights alignment with other frameworks such as the Global Reporting Index (GRI) and the Dow Jones Sustainability Index (DJSI), and familiarizes participants with the background, methodology, and questionnaire.

The European Parliament is currently under pressure to reject the Uzbekistan Partnership and Cooperation Agreement, and cease the trade of textiles with Uzbekistan. This pressure stems from strong evidence that forced labor and child labor continues to remain a nationwide practice in Uzbekistan, despite earlier reports of compliance.

Blackbaud OutcomesTM is an impact investing and measurement solution brought to you by MicroEdge + Blackbaud that allows foundations and corporate giving organizations to track the impact of their grants using a standard results measurement taxonomy.

Novartis ranked third in the 2016 Access to Medicine Index (up from 4th place in 2014), in recognition of its efforts to improve worldwide access to healthcare. The Company tops the industry in access-to-medicine management and capacity building.